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Crotoxin (CTX) is the main neurotoxic component of Crotalus durissus terriﬁcus snake
venom. It inhibits tumour growth and modulates the function of macrophages, which are
essential cells in the tumour microenvironment. The present study investigated the effect
of CTX on the secretory activity of monocultured macrophages and macrophages co-
cultivated with LLC-WRC 256 cells. The effect of the macrophage secretory activities on
tumour cell proliferation was also evaluated. Macrophages pre-treated with CTX (0.3 mg/
mL) for 2 h were co-cultivated with LLC-WRC 256 cells, and the secretory activity of the
macrophages was determined after 12, 24 and 48 h. The co-cultivation of CTX-treated
macrophages with the tumour cells caused a 20% reduction in tumour cell proliferation.
The production of both H2O2 and NO was increased by 41% and 29% after 24 or 48 h of co-
cultivation, respectively, compared to the values for the co-cultures of macrophages of
control. The level of secreted IL-1b increased by 3.7- and 3.2-fold after 12 h and 24 h of co-
cultivation, respectively. Moreover, an increased level of LXA4 (25%) was observed after
24 h of co-cultivation, and a 2.3- and 2.1-fold increased level of 15-epi-LXA4 was observed
after 24 h and 48 h, respectively. Boc-2, a selective antagonist of formyl peptide receptors,
blocked both the stimulatory effect of CTX on the macrophage secretory activity and the
inhibitory effect of these cells on tumour cell proliferation. Taken together, these results
indicate that CTX enhanced the secretory activity of macrophages, which may contribute to
the antitumour activity of these cells, and that activation of formyl peptide receptors ap-
pears to play a major role in this effect.
 2013 Elsevier Ltd. All rights reserved.0; fax: þ55 11 2627
.br, sandracoccuzzo@
. All rights reserved.1. Introduction
Macrophages play a critical role in a host’s defense
against cancer. Several studies have demonstrated that
when monocytes/macrophages are activated under in vitro
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Macrophages exist in two distinct polarisation states, as
classically activated macrophages (M1 macrophages) and
alternatively activated macrophages (M2 macrophages)
(Mantovani et al., 1992; Gordon, 2003). In the initial stage
of tumour progression, M1 macrophages release com-
pounds that are cytotoxic to cancer cells, such as reactive
nitrogen/oxygen intermediates, tumour necrosis factor a
(TNF-a), IL-1b and IL-6 (Roitt and Delves, 1992). The reac-
tive oxygen species (ROS) that are formed during the res-
piratory burst of the mononuclear phagocytes have been
implicated in the mechanism of killing tumour cells. In
addition, ROS act as signalling molecules to induce the
production of IL-1b and the expression of inducible nitric
oxide (iNOS) (Song et al., 2002). Nitric oxide (NO) has been
shown to be toxic to tumour cells via mitochondrial dam-
age, inhibition of DNA synthesis and disruption of the ﬂux
of substrates through the tricarboxylic acid cycle (Hibbs
et al., 1988; Lancaster and Hibbs, 1990; Pellat et al., 1990).
The production of IL-6 and TNF-a, which have a regulatory
effect on tumour growth, has been implicated as one of the
cytostatic/cytocidal factors in the direct anti-tumour ac-
tivity of the activated macrophages (Hamilton and Adams,
1987; Lewis and McGee, 1992; Paulnock, 1992; Arinaga
et al., 1992).
During tumour progression, the secretory activities of
these macrophages may become altered, resulting in their
being unable to lyse tumour cells (Mosmann et al., 1986;
Mantovani et al., 2004, 2005; Sica et al., 2008; for re-
view). Additionally, the lipoxygenase pathway is inhibited
in macrophages upon their contact with tumour cells
(Calorini et al., 2005). The inhibitory effect of tumour cells
on the lipoxygenase activity of macrophages might be
important for tumour progression because the lip-
oxygenase products, such as the lipoxins (LXs) and their
analogues, are lipid mediators with anti-angiogenic and
anti-tumour activities (Fierro et al., 2002; Hao et al., 2011).
LXs are eicosanoids produced from arachidonic acid via the
5-lipoxygenase (5-LO) and 15-lipoxygenase (15-LO) path-
ways (Serhan et al., 1984) that are involved in a range of
physiological and pathophysiological conditions (Serhan
et al., 1995). LXA4 and LXB4 are the main LXs produced in
mammals. The acetylating of cyclooxygenase-2 (COX-2) by
aspirin (Serhan et al., 1995), or in the absence of aspirin, via
S-nitrosylation of COX-2 (Birnbaum et al., 2006), or P450-
derived 15R-HETE that is substrate for leucocyte 5-LO
(Clària et al., 1996), lead to the transcellular biosynthesis
of 15-epi-lipoxins (ATL). Released ATL, in particular the 15-
epi-LXA4 form, has more potent and longer acting effects
than does the native 15S-containing LX form because it is
less rapidly inactivated (Serhan et al., 1995; Serhan, 2005;
for review). The native LXs and their natural analogue 15-
epi-LXA4 modulate inﬂammation-related signals and may
play a role in regulating the genesis and development of
tumours (Serhan, 2005; Li et al., 2008) and exert their ef-
fects via binding to G-protein-coupled LXA4 receptor
(ALXR, also termed FRL1) (Fiore et al., 1994; Ye and Boulay,
1997; Rabiet et al., 2007).
CTX displays an antitumour effect, reducing tumour
growthboth in vivo and invitro (Newmanet al.,1993;Donato
et al.,1996; Cura et al., 2002; Sampaio et al., 2010 for review).Crotoxin (CTX), the main toxic component of the venom of
the South American rattlesnake Crotalus durissus terriﬁcus, is
a heterodimeric complex consisting of the basic and toxic
phospholipase A2 and an acidic, non-toxic, nonenzymatic
component named crotapotin (Slotta and Frankel-Conrat,
1938; Bon et al., 1988). In addition to its in vivo anti-
tumour activity, CTX, administered intramuscularly daily,
inhibited the growth of Lewis lung carcinoma and MX-1
human mammary carcinomas (Newman et al., 1993;
Donato et al., 1996; Cura et al., 2002). Five days of treat-
mentwith CTX signiﬁcantly inhibited thegrowthof tumours
in rat paws (Brigatte, 2005). The inhibitory effect of the toxin
on tumour growth is abolished by pretreatment with Boc-2,
a selective antagonist of the formyl peptide receptor (Faiad
et al., 2008).
The immunomodulatory effect of C. durissus terriﬁcus
venom (CdtV) is retained by its major toxin, CTX, and by the
isolated subunits of CTX (CA and CB) (Sampaio et al., 2010
for review). In addition, peritoneal macrophages incu-
bated with CTX released higher LXA4 levels than did non-
treated cells (Sampaio et al., 2006b). A single dose of sub-
cutaneously administered CTX promoted an increase of
H2O2 release, NO production and IL-1b and TNF-a secretion
by the peritoneal macrophages obtained from Walker 256
tumour-bearing rats fourteen days later. Concomitantly, a
reduction in tumour size was observed (Costa et al., 2010).
Despite the intriguing results described above, the effect
of CTX on the secretory activity of peritoneal macrophages
in a tumour microenvironment has not been determined.
The present study investigated the following issues: 1) the
effect of CTX on the secretory activity of macrophages co-
cultured with LLC-WRC 256 cells, 2) the effect of CTX on
tumour cell proliferation and 3) the possible involvement
of formyl peptide receptors in the actions of the toxin.
2. Materials and methods
2.1. Animals
Male Wistar rats weighing 160–180 g were used in this
study. All the procedureswere performed in accordancewith
the guidelines for animal experimentation, and the Ethical
Committee for the Use of Animals of the Butantan Institute
approved the protocol (CEUAIB, protocol number 631/09).
2.2. Crotoxin
Lyophilised venom of C. durissus terriﬁcus was obtained
from the Laboratory of Herpetology, Butantan Institute, São
Paulo, Brazil, and stored at 20 C. Crude venom solution
was subjected to anion-exchange chromatography as pre-
viously described by Rangel-Santos et al. (2004), using a
Mono-Q HR 5/5 column in an FPLC system (Pharmacia,
Uppsala, Sweden). The fractions (1 ml/min) were eluted
using a linear gradient of NaCl (0–1 mol/L in 50 mmol/L
Tris–HCl, pH 7.0). Three peaks (p1, p2 and p3) were ob-
tained: p2 corresponded to the pure CTX fraction (about
60% of the crude venom); peaks 1 and 3 included the other
CdtV toxins. Prior to pooling, the fractions containing CTX
were tested for homogeneity by non-reducing sodium
dodecyl sulphate-polyacrylamide gel electrophoresis
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was assessed by a colourimetric assay using a synthetic
chromogenic substrate (Lobo-de-Araujo & Radvanyi, 1987).
2.3. Peritoneal cell preparation
The animals were euthanised in a CO2 chamber, and the
peritoneal cavity was opened. The peritoneal cavity was
washedwith 10ml of cold phosphate-buffered saline (PBS),
pH 7.4. After a gentle massage of the abdominal wall, the
peritoneal ﬂuid containing the resident macrophages was
collected. The number of total peritoneal cells was deter-
mined using a Neubauer’s chamber, and differential counts
were performed on smears stained with a panchromatic
dye (Rosenfeld, 1971). Samples from individual animals
were used for all the measurements. The assays were al-
ways performed in duplicate.
2.4. tumour cell culture
The cell line used was a carcinoma cell line, the LLC-
WRC 256 rat Walker tumour line established by Hull
(1953), which was obtained from a repository of animal
cell cultures in the Dunn School of Pathology, Oxford Uni-
versity, UK. The cells were grown in minimum essential
medium (MEM) supplemented with 10% foetal calf serum
and antibiotics (penicillin 50 U/ml and streptomycin
50 m kg/ml) in a humidiﬁed atmosphere of 5% CO2 and 95%
air at 37 C. For the experiments, the cells were seeded at a
density of 5  104 cells/mL in the medium described above.
2.5. Co-culture conditions and treatment with CTX and Boc-2
The co-culture procedure thatwasusedwasbasedon the
method described by Hauptmann et al. (1993). Co-cultures
were established in 96-well tissue culture plates to deter-
mine the hydrogen peroxide (H2O2) liberation and nitric
oxide (NO) production and to assess tumour cell prolifera-
tion. LLC-WRC 256 tumour cells (1  104/100 mL per well)
were allowed to adhere for 3 h, washed with PBS and
incubated with fresh medium for 24 h. The adherent peri-
toneal macrophages (2  105) were pre-treated with CTX
(0.3 mg/mL) for 2 h, washed, collected and transferred to a
96-well tissue culture plate containing 2 X 104 tumour cells
per well. The macrophage cultures and co-cultures were
maintained for 24 and 48 h at 37 C in a 5% CO2 humidiﬁed
atmosphere. To determine the production of IL-1b, TNF-a,
IL-6, LXA4 and 15-epi-LXA4, the adherent peritoneal mac-
rophages (5  105) were pre-treated with CTX (0.3 mg/mL)
for 2 h, washed, collected and transferred to a 24-well plate
containing LLC-WRC 256 tumour cells (5  104 per well)
plated in fresh medium 24 h beforehand. The macrophage
cultures andco-culturesweremaintained for12, 24and48h
at 37 C in a 5% CO2 humidiﬁed atmosphere. This resulted in
a macrophage:tumour ratio of 10:1. All the experiments
were performed in triplicate, with macrophages from three
different donors. The concentration of CTX (0.3 mg/mL) was
the same as that used in previous research (Sampaio et al.,
2003, 2006a,b), which did not exhibit cytotoxicity as
assessedbyTrypanblue exclusion andbyﬂowcytometry for
the exclusion of propidium iodide.The involvement of the formyl peptide receptor (ALX or
FPR1) in the stimulatory effect of CTX on the secretory ac-
tivities of macrophages was evaluated in cells pre-treated
with 100 mM of Boc-2 (butoxycarbonyl-Phe-Leu-Phe-Leu-
Phe, Phoenix Pharmaceutical Inc, USA), a selective antag-
onist of formyl peptide receptors, for 15 min at 37 C
(Scannell et al., 2007) before incubation with CTX, as
described above.
2.6. Hydrogen peroxide production
The production of H2O2 was measured as described by
Pick et al. (1981), using phenol red. This assay is based on a
horseradish peroxidase-dependent conversion of phenol
red into a coloured compound by H2O2. A phenol red so-
lution (PRS) containing 140 mM NaCl; 10 mM potassium-
phosphate buffer, pH 7.0; 5 mM dextrose; 0.28 mM
phenol red; and 8.5 U/mL of horseradish peroxidase was
used for the H2O2 determination. A ﬁnal volume of 7.4 ml
was obtained using Hank’s solution. After 24 h of co-
culture, the supernatants were collected, and 100 mL of
phenol red solution was added into each well of 96-well
ﬂat-bottomed tissue culture plates (Corning, NY), which
were incubated in a humidiﬁed atmosphere at 37 C for 1 h.
Vertical row no.1, which lacked cells, was ﬁlled with 100 mL
of PRS per well. The second and third vertical rows were
used to establish the H2O2 standard curves. These wells
were ﬁlled with 100 mL of PRS, to which was added 10 mL of
a H2O2 solution, resulting in a ﬁnal concentration of H2O2
ranging from 5 to 40 mM. The subsequent rows contained
100 mL of PRS without (basal H2O2 production) or with
phorbol myristate acetate (100 ng). After 60 min of incu-
bation at 37 C, the reactionwas stopped by the addition of
10 mL of a 1 N NaOH solution. The hydrogen peroxide-
dependent phenol red oxidation was spectrophotometri-
cally measured at 620 nm using a Titertek Multiscan
apparatus. The concentration of H2O2 was calculated from
the absorbance measurements and expressed as nano-
moles of H2O2 per 2  105 cells.
2.7. Nitric oxide production
To determine the nitric oxide production, nitrite was
measured in the supernatants of cultures or co-cultures
based on the method described by Ding et al. (1988). At
the end of the culture period, 50 or 100 mL of the super-
natant was removed and incubated with an equal volume
of Griess reagent (1% sulfanilamide, 0.1% naphthylene
diamine dihydrochloride, 2.5% H3PO4) at room temperature
for 10min. The absorbancewas determined using a Titertek
Multiscan apparatus at 550 nm. The nitrite concentration
was determined by using sodium nitrite as the standard.
Cell-free medium contained 0.2–0.3 nmol of NO2 /well; this
value was determined in each experiment and subtracted
from that obtained with cells.
2.8. Proliferation assay
The proliferation of tumour cells was assessed using the
3-(4,5 dimethylthiazol-2-thiazyl)-2,5-diphenyl-tetrazo-
lium bromide (MTT, Amresco) assay, based on the method
Fig. 1. Effect of CTX on Hydrogen Peroxide and Nitrite Production by Macrophages monoculture and macrophages co-cultivated with LLC-WRC 256 tumour cells.
Macrophages (M4) were obtained from the peritoneal cavity of rats (resident), treated with CTX (0.3 mg/mL) or RPMI 1640 Medium (control), at 37 C for 2 h.
After this period, the cells were cultivated in 96-well tissue culture plate or co-cultivated 96-well tissue culture plate containing tumour cell. (A) After 24 h,
hydrogen peroxide production (nmoles H2O2/2  105 cells) was determined in the presence of PMA. (B) For NO2 production, the results are expressed as mi-
cromoles of NO2 by 2  105 cells for 48 h. The results are expressed as means  SEM of values obtained from three different experiments performed with
duplicate. *P < 0.05, signiﬁcantly different from control group of co-culture. #P < 0.05, signiﬁcantly different from control group of M4 monoculture.
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Cultured and co-cultured macrophages were maintained in
RPMI 1640 culture medium at 37 C in an environment of
5% CO2 for 48 h. After this period, 30 mL of MTT solution
(5 mg/mL) was added, and the cultures were incubated for
3 h at 37 C. During the incubation, living cells convert the
tetrazolium component of the dye solution into formazan
crystals. The formazan crystals were dissolved by adding
100 mL of PBS containing 10% SDS and 0.01 N HCl and
incubating the mixture for 18 h at 37 C in 5% CO2. The
absorbance was read on a multiwell scanning spectropho-
tometer (ELISA reader) at 570 nm. The number of cells was
estimated by comparison to a standard curve prepared
using known numbers of fresh live cells added to the plates
immediately before staining.
2.9. Cytokine quantiﬁcation
The cytokines present in the supernatants of the cell
cultures were quantiﬁed using an ELISA. Brieﬂy, ELISA
plates (Immuno Maxisorp; Nunc, NJ) were coated with
mouse anti-rat monoclonal or polyclonal antibodies
against IL1-b, TNF-a and IL-6 (R&D Systems, Minneapolis,
MN). The plates were incubated overnight at room tem-
perature and blocked for 1 h at room temperature on a
shaker before adding the samples and standards and
incubating for 2 h. Biotinylated secondary antibodies were
added before 2 h of incubation, and then, peroxidase-
conjugated streptavidin was added before 20 min of incu-
bation. Tetramethyl benzidine (TMB), a peroxidase sub-
strate, was added, and the plates were incubated in the
dark for 20 min for colour development. The reaction was
stopped with 2 N sulphuric acid, and the plates were read
using dual wavelengths (465 and 590 nm) on a microplate
reader (Spectra Max 190, Molecular Devices). The cytokine
concentrations were determined by comparison to a stan-
dard curve prepared using the recombinant murinecytokines (R&D Systems) that could be detected at 4–10 pg/
mL. The cytokine concentrations were expressed as the
amount of induced cytokine in picograms per 106
macrophages.2.10. Extraction and quantiﬁcation of eicosanoids
The production of LXA4 and 15-epi-LXA4 was deter-
mined from cell-free supernatants acidiﬁed with 1 N HCl to
pH 3.4–3.6 and passed slowly through an octadecylsilyl
silica column (C18 Sep-Pak column, Waters Corporation,
USA) that had been pre-washed with 10 ml of absolute
ethanol and 10 ml of water. After activating the column
with 10 ml of water, 2 ml of absolute ethanol and 2 ml of
water, the eicosanoids were eluted from the column with
1 ml of water, 1 ml of ether and 2ml of methyl formate, and
the samples were dried under a stream of nitrogen. LXA4
and 15-epi-LXA4 concentrations were determined using an
ELISA kit (Neogen Corporation, USA). The sensitivity of the
assays was 2 ng/mL.2.11. Statistical analysis
Statistical analyses of the differences between the
groups were performed according to Glantz (1997) using
GraphPad InStat software, version 3.01 (GraphPad Software
Inc., San Diego, CA, USA). A one-way analysis of variance
followed by Tukey’s test was used for multiple comparisons
(all pairs of groups) of the values from the assays using the
Boc-2 antagonist. To analyse the data from the other assays,
a one-way analysis of variance was used, followed by
Bonferroni’s test for multiple comparisons against a single
control or by an unpaired Student t-test to compare two
groups. Differences with P < 0.05 were considered statis-
tically signiﬁcant. The results are presented as the mean
values  standard error of means.
Fig. 2. Effect of CTX on Cytokine Production by Macrophages Monoculture and Macrophages Co-cultivated with LLC-WRC 256 Tumour Cells. Macrophages (M4)
were obtained from the peritoneal cavity of rats (resident), treated with CTX (0.3 mg/mL) or RPMI 1640 Medium (control), at 37 C for 2 h. After this period, the
cells were cultivated in 24-well tissue culture plate or co-cultivated 24-well tissue culture plate containing tumour cells. For determination of levels of cytokine,
cell-free supernatants from monocultures and co-cultures were collected after 12 h (A1, B1 and C1) and 24 h (A2, B2 and C2) and were determined by ELISA
(picograms per milliliter). IL-1b production after 24 h M4monoculture was not detected (ND). The results are expressed as means  SEM of values obtained from
three different experiments performed with duplicate. *P < 0.05, signiﬁcantly different from respective Control group of M4 monoculture and co-culture.
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3.1. CTX increased the hydrogen peroxide (H2O2) liberation
and nitric oxide (NO) production of macrophage monocultures
and macrophages co-cultivated with LLC-WRC 256 cells
Treatment with CTX for 2 h increased the amount of
H2O2 liberated by the macrophage monocultures (60%) and
by macrophages co-cultivated with tumour cells (41%) at24 h of incubation (Fig. 1A). After this period, this oxygen
reactive molecule was not detected in either culture. As
shown in Fig. 1B, pre-treatment with CTX stimulated the
NO production of macrophage monolayers (38%) and of
macrophages co-cultivated with tumour cells (29%) at 48 h
of incubation. The LLC-WRC 256 cell cultures produced
very low levels of both reactive molecules (data not shown).
Interestingly, the co-cultures of control macrophages with
the tumour cells exhibited a marked reduction of H2O2
Fig. 3. Effect of Macrophages pre-treated with CTX on the proliferation of
LLC-WRC 256 Tumour Cells. Macrophages (M4) were obtained from the
peritoneal cavity of rats (resident), treated with CTX (0.3 mg/mL) or RPMI
1640 Medium (control), at 37 C for 2 h. After this period, the cells were
cultivated in 96-well tissue culture plate containing tumour cell (LLC Cell), at
37 C for 48 h. After this period, the cell number was accessed by MTT as
described in Material and Methods. The results are expressed as
means  SEM of values obtained from three different experiments per-
formed with duplicate. *P < 0.05, signiﬁcantly different from control group.
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compared to the control macrophages, suggesting that the
tumour cells exerted a suppressor activity on macrophage
function.
3.2. CTX stimulated the secretion of cytokines by macrophage
monocultures and macrophages co-cultivated with LLC-WRC
256 cells
The secretion of cytokines by macrophages in mono-
cultures and in co-cultures with LLC-WRC 256 cells was
assessed by performing multiplexed cytokine assays on the
culture supernatants. Macrophages pre-treated with CTX
demonstrated increased secretion of the IL-6 cytokine
(3.19-fold at 12 h, Fig. 2A1; 80% at 24 h, Fig. 2A2) but
signiﬁcantly decreased secretion of the IL-1b and TNF-a
cytokines at 12 h (48%, Fig. 2B1 and 57%, Fig. 2C1, respec-
tively) when compared to the monoculture control. After
24 h, the levels of IL-1b were undetectable (Fig. 2B2). No
differences in the levels of TNF-a secreted by the two sets of
macrophages were observed (Fig. 2C2). Co-culturing mac-
rophages in the presence of tumour cells enhanced their IL-
6 production, but pretreatment with CTX did not alter the
level of this cytokine at the experimental time points,
compared to the control group (Fig. 2A1 and A2). In
contrast, increased secretion of IL-1b (3.7-fold at 12 h,
Fig. 2B1; 3.24-fold at 24 h, Fig. 2B2) was observed. Inter-
estingly, the level of this cytokine was decreased (76%) in
co-cultures at 12 h, compared to the level detected in
macrophage monocultures (Fig. 2B1), suggesting a sup-
pressive action of the tumour cells on the secretion of this
mediator. Similarly, co-cultured cells secreted less TNF-a
(20%) (Fig. 2C1) compared to monocultured cells. However,
treatment with CTX did not affect TNF-a secretion by the
macrophages co-cultured with tumour cells at 12 h or at
24 h (Fig. 2C1 and C2).At 48 h, secreted cytokines were not detected in either
the monocultures or the co-cultures (data not shown). The
monocultures of LLC-WRC 256 cells secreted low levels of
the cytokines analysed (data not shown).
3.3. Macrophage pre-treatment with CTX inhibited the
proliferation of LLC-WRC 256 cells
Because CTX has been demonstrated to stimulate the
secretory activity of macrophages and of macrophages co-
cultivated with LLC-WRC 256 cells, we evaluated the ef-
fect of macrophages treated with this toxin on tumour cell
proliferation. As shown in Fig. 3, the results of the MTT
assay demonstrated that tumour cell proliferation was
inhibited (20%) at 48 h of co-culture with macrophage pre-
treated with CTX. This effect was not due to the loss of
membrane integrity because the viability of the macro-
phages and tumour cells in monocultures was higher than
95% after 48 h, as assessed by Trypan blue exclusion.
3.4. Involvement of formyl peptide receptors in the
modulatory activity of CTX on macrophages co-cultivated with
LLC-WRC 256 cells
Boc-2, a selective formyl peptide receptor antagonist,
abolished the stimulatory effect of pretreatment with CTX
on H2O2 liberation and NO production by the macrophages
in co-cultures (Fig. 4A and B, respectively), when compared
to control co-cultures. Pretreatment with Boc-2 also abol-
ished the increase in the level of secreted IL-1b observed at
12 and 24 h of co-culture (Fig. 4C1 and C2) and the increase
in the level of TNF-a observed at 24 h of co-culture
(Fig. 4C2). Macrophages pre-treated with Boc-2 for
15 min before CTX treatment did not inhibit the prolifera-
tive activity of tumour cells in co-cultures when compared
to the control co-cultures (Fig. 5). Boc-2 per se did not have
an effect on macrophage activity. These results demon-
strate the critical involvement of FPR1 in the stimulatory
effect of CTX on the macrophage secretory activities and
anti-proliferative function.
3.5. CTX induced eicosanoid synthesis by macrophages
Macrophage monocultures previously incubated in the
presence of CTX displayed increased LXA4 secretion (59% at
24 h, Fig. 6B). Differences in the levels of LXA4 were not
observed at 12 h (Fig. 6A) or at 48 h (Fig. 6C). In contrast,
CTX enhanced the 15-epi-LXA4 production by macrophage
monocultures in all the time periods evaluated (9.3-fold at
12 h, Fig. 6D; 5.5-fold at 24 h, Fig. 6E; 2.7-fold at 48 h,
Fig. 6F), compared to control monocultures. The superna-
tants of co-cultures of macrophages pre-incubated with
CTX and LLC-WRC 256 cells produced signiﬁcantly
increased LXA4 levels only at 24 h (25%, Fig. 6B). Differences
in the levels of LXA4 in the co-cultures of CTX-treated
macrophages and tumour cells were not observed at 12 h
(Fig. 6A) or 48 h (Fig. 6C). As shown in Fig. 6D, treatment
with CTX did not affect the levels of 15-epi-LXA4 secreted
by the macrophages in co-cultures with the tumour cells.
However, the 15-epi-LXA4 levels were gradually induced
over 24 h (2.3-fold, Fig. 6E) and 48 h (2.1-fold, Fig. 6F), when
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pre-incubated with culture medium and LLC-WRC 256
tumour cells). The level of 15-epi-LXA4 in the LLC-WRC 256
cell monocultures was below the limits of sensitivity of the
assay that was used (data not shown).
4. Discussion
In this study, an experimental model represented by
macrophages cultivated together with tumour cells at a
10:1 ratio was used to evaluate the secretory activity of
macrophages pre-treatedwith CTX growing in contact with
tumour cells and the inﬂuence of this contact on tumour
cell proliferation.
The data presented here demonstrate that macrophages
pre-treated with CTX (0.3 mg/mL) for 2 h increased their
release or secretion of effector molecules such as H2O2, NO
and cytokines and exhibited a cytotoxic effect on tumour
cells. It is important to mention that the proliferation and
nitric oxide production assays was determined usingFig. 4. Effect of Boc-2 on CTX-induced of secretory Activity of Macrophages Co-cul
from the peritoneal cavity of rats (resident), incubated in the presence of Boc-2 (100
incubated with CTX (0.3 mg/mL) or RPMI 1640 Medium (control), at 37 C for 2 h. Aft
containing tumour cell. (A) After 24 h, hydrogen peroxide production (nmoles H2O
duction, the results are expressed as micromoles of NO2 by 2  105 cells for 48 h.
monocultures and co-cultures collected after 12 h (C1) and 24 h (C2) by ELISA a
means  SEM of values obtained from three different experiments performed with
**P < 0.05, signiﬁcantly different from Boc-2þCTX group. #P < 0.05, signiﬁcantly dmacrophages co-cultivatedwith three different tumour cell
lines, such as, LLC-WRC 256 tumour cells, B16F10 murine
melanoma cells and human breast cancer cell line MCF-7.
Likewise that observed in the co-cultures with LLC-WRC
256 cells, macrophages pre-treated with CTX, inhibited
proliferation of B16–F10 and MCF-7 (31% and 38%, respec-
tively, data not shown). Additionally, an increase of pro-
duction of NO in these co-cultures (26% and 50%,
respectively, data not shown) was observed. Therefore,
since the same effect observed regardless the tumour cell
type, only the LLC WRC 256 lineage was performed in
subsequent evaluation.
As shown in Fig. 1A, a marked induction of H2O2 liber-
ation by CTX was observed after 24 h in both macrophage
monocultures and co-cultures. After this period, liberation
of H2O2 occurs in lower levels. Treating the macrophages
with CTX resulted in an increased production of NO after
48 h of culture, as shown in Fig. 1B. Nitric oxide can
modulate peroxiredoxins, an important peroxidase family
that reduce H2O2 and other peroxides and hence, exerts antivated with LLC-WRC 256 Tumour Cells. Macrophages (M4) were obtained
mM), for 15 min. After this period, the cells were washed with PBS and then
er this period, the cells were washed and cultivated in the tissue culture plate
2/2  105 cells) was determined in the presence of PMA. (B) For NO2 pro-
The levels of IL-1b cytokine were determined in cell-free supernatants from
nd are expressed as picograms per milliliter. The results are expressed as
duplicate. *P < 0.05, signiﬁcantly different from control group of co-culture.
ifferent from M4 monolayer.
Fig. 5. Effect of Boc-2 on the anti-proliferative activity of macrophages
treated with CTX on LLC-WRC 256 Tumour Cells. Macrophages (M4) were
obtained from the peritoneal cavity of rats (resident), incubated in the
presence of Boc-2 (100 mM), for 15 min. After this period, the cells were
washed with PBS and then incubated with CTX (0.3 mg/mL) or RPMI 1640
Medium (control), at 37 C for 2 h. After this period, the cells were washed
and cultivated in the tissue culture plate containing tumour cell (LLC Cell), at
37 C for 48 h. After this period, the cell number was accessed by MTT as
described in Material and Methods. The results are expressed as
means  SEM of values obtained from three different experiments per-
formed with duplicate. *P < 0.05, signiﬁcantly different from control group.
**P < 0.05, signiﬁcantly different from Boc-2þCTX group.
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least partially, the lower levels of amounts of H2O2 at 24 h
in both monocultures and co-cultures.
In addition to examining the production of the oxygen
and nitrogen reactive molecules, the production of cyto-
kines was evaluated. IL-6 and TNF-a are humoral factors
that are associated with the suppression of tumour cell
growth (Paulnock, 1992; Arinaga et al., 1992). Enhanced
production of IL-6 was observed in the co-cultures, as
shown Fig. 2A1 and A2. IL-6 production is known to often
preceded by increased levels of TNF-a and IL-1b (Olman
et al., 2004); however, IL-6 secretion was not modulated
by CTX in any time period evaluated. Similarly, CTX treat-
ment did not modulate the secretion of TNF-a, as shown in
Fig. 2C1 and C2. IL-1b production was rapidly enhanced in
co-cultures of CTX-treated macrophages and tumour cells
at 12 h and was maximal at 24 h (Fig. 2B1 and B2,
respectively).
Moreover, monocultures of macrophages pre-treated
with CTX demonstrated increased IL-6 secretion at 12 h
and 24 h (Fig. 2A1 and A2) and reduced secretion of IL-1b
(Fig. 2B1 and B2) and TNF-a at 12 h, as shown in Fig. 2C1
and C2, which is compatible with the anti-inﬂammatory
proﬁle described for this toxin (Nunes et al., 2010; da
Silva et al., 2013). The duality of the effects of CTX,
depending on the model investigated, reinforces the ﬁnd-
ings reported in the literature showing that CTX accounts
for the immunomodulatory action of toxin (Sampaio et al.,
2010; for review). Another important observation is that
the production of oxygen and nitrogen reactive moleculesand the secretion of IL-1b were signiﬁcantly decreased in
control co-cultures (macrophages pre-treated with culture
medium only), demonstrating that contact with tumour
cells decreased the secretory capacity of the macrophages.
Macrophages release large amounts of H2O2, NO and
cytokines, and treatment with CTX increases their secre-
tion; these secretory products of macrophages are known
to interfere with tumour development. Our objective was
to study certain properties of this phenomenon and the
mechanisms involved in the anti-tumour effect of CTX.
In this regard, several studies have suggested that the
tumour microenvironment decreased the ability of mac-
rophages to kill tumour cells (Szuro-Sudol and Nathan,
1982; Ting and Hargrove, 1982; Alleva et al., 1994). This
phenomenon of down-regulation of macrophage meta-
bolism was also observed after co-culturing macrophages
with tumour cells (Mitra et al., 2002). The results obtained
in this study suggest that pre-treatment with CTX blocks
the suppressive action of tumour cells on the secretory
activity of macrophages. Studies have suggested that the
appropriate activation of M1 macrophages or the conver-
sion of M2 macrophages to M1 macrophages in tumours
would be beneﬁcial for cancer therapy (Watkins et al.,
2007; Hagemann et al., 2008). Our data support this
hypothesis.
Cytotoxicity against tumour cells, as well the expression
of microbicidal factors, is dependent on the activation of
macrophages and is closely related with the pattern of
expression of several inﬂammatory mediators. The process
of activation includes the generation of cytokines such as
TNF-a, IL-6 and IL-1b and reactive oxygen and nitrogen
intermediates (Martin and Edwards, 1993; Song et al.,
2002; Mantovani et al., 2004). The data presented here
demonstrate that the proliferation of tumour cells culti-
vated in the presence of macrophages previously treated
with CTX was inhibited within 48 h (Fig. 3), suggesting the
up-regulation of macrophage cytotoxic activities toward
the tumour cells. These results indicate that pre-treatment
of peritoneal macrophages with CTX increased their
metabolism and that their cytotoxic effect on tumour cells
occurred through cell–cell contact. Our data are consistent
with the results of Taniguchi et al. (2010), who demon-
strated that cell–cell contact is critical for the cytotoxic
effect of activated lung macrophages on tumour cells,
because isolating these macrophages from the tumour cells
using a culture insert blocks the cytotoxic effect of the
macrophages on tumour cell proliferation.
Another interesting fact to consider is that the lip-
oxygenase pathway of murine peritoneal macrophages was
affected by contact with tumour cells, resulting in the
depletion of lipoxygenase products, such as LTB4 and LXs, in
the tumour microenvironment (Calorini et al., 2005). The
inhibitory effect of tumour cells on the lipoxygenase ac-
tivity of macrophages appears to be important for tumour
progression (Calorini et al., 2005).
In this regard, studies have demonstrated that LXA4 and
its analogues effectively suppresses hepatocarcinoma
in vitro and in vivo. LXs exert their biological actions by
binding to speciﬁc high afﬁnity G protein-coupled re-
ceptors, FPR2/ALX, that belong to the formyl-peptide re-
ceptor family (Chiang and Serhan, 2006; Ye et al., 2009).
Fig. 6. Effect of CTX on induction of LXA4 and 15-epi-LXA4 synthesis by Macrophages Monoculture and Macrophages Co-cultivated with LLC-WRC 256 Tumour
Cells. Macrophages (M4) were obtained from the peritoneal cavity of rats (resident), treated with CTX (0.3 mg/mL) or RPMI 1640 Medium (control), at 37 C for
2 h. After this period, the cells were cultivated in 24-well tissue culture plate or co-cultivated 24-well tissue culture plate containing tumour cells. The levels of
lipoxin A4 (LXA4) and 15-epi-LXA4 (stable analogue-ATL), determined by ELISA, in cell-free supernatants from monocultures and co-cultures collected after 12 h
(A, D), 24 h (B, E) and 48 h (C, F), as described in Material and Methods. The results are expressed as means  SEM of values obtained from three different
experiments performed with duplicate. *P < 0.05, signiﬁcantly different from respective control group of M4 monoculture and co-culture.
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also a member of the FPR family (Machado et al., 2006;
Stenfeldt et al., 2007). Our data demonstrate that pre-
treatment with Boc-2 (100 mM) abolished the stimulatory
effects of CTX on the secretory activity of macrophages co-
cultivated with tumour cells, as shown in Fig. 4A, B, C1 and
C2. Interestingly, pretreatment with Boc-2 blocked the
cytotoxic activity of CTX-treated macrophages on tumour
cell proliferation (Fig. 5), suggesting that FPR are crucial for
the action of this toxin.
Our previous work demonstrated that Zileuton, a 5-
lipoxygenase (5-LO) inhibitor, abolished the inhibitory ef-
fect of CTX on macrophage phagocytosis (Sampaio et al.,2006b) and the stimulatory effect of this toxin on NO
production bymacrophages (unpublished data), suggesting
that macrophage function by CTX is regulated through the
production of lipoxygenase-derived mediators. In addition,
CTX induced an increase in LXA4 production (Sampaio
et al., 2006b). Macrophage effectors that mediate cellular
cytotoxicity, such as cytokines and inducible nitric oxide
synthase (iNOS), play critical roles in tumour progression
(Keller et al., 1990). Recent insights have begun to reveal
new roles for the LXs in modulating this process (Hao et al.,
2011). It is important to point out that Dakin et al. (2012)
showed that IL1-b induces LXA4 release and up-
regulation of FPR2/ALX expression at 24 h at least 72 h in
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are involved in this modulation (Dakin et al., 2012).
In the results presented here, CTX-treated macrophages
demonstrated increased production of LXA4 by 24 h in
monocultures or in co-cultures with tumour cells (Fig. 6B).
Moreover, a 2 h treatment with CTX enhanced the produc-
tion of 15-epi-LXA4 by the macrophages at 12 h, 24 h and
48 h in monocultures or in co-cultures (Fig. 6D, E and F).
LXs biosynthesis proceeds via 15-LO-mediated conver-
sion of AA to 15-hydroxyeicosatetraenoic acid (HETE),
transformed via 5-LO to LXA4 and LXB4 during cell–cell
interactions (Spite and Serhan, 2010; for review). In the
presence of aspirin, acetylated COX-2, which both prevents
the generation of prostaglandins and activates the oxida-
tion of AA to 15R-HETE (Serhan et al., 1995). This inter-
mediate, like 15S-HETE, is transformed via 5-LO to generate
epimeric lipoxins, termed aspirin-triggered or 15-epi-lip-
oxins (ATL), such as 15-epi-LXA4, are more stable and more
potent analogues (Parkinson, 2006). In addition, 15-epi-
lipoxin biosynthesis can also be initiated by cytochrome
P450 enzymes catalysed generation of 15R-HETE from AA,
followed by 5-LO metabolism. This pathway may be
responsible for 50% of the ATL biosynthesis in the absence
of aspirin (Clària et al., 1996). Others studies demonstrated
that statins promote the formation of 15-epi-LXA4, from AA
via the S-nitrosylation of COX-2 (Birnbaum et al., 2006).
Similar to aspirin acetylation of COX-2, S-nitrosylated COX-
2 produces 15R-HETE, both are converted by leucocyte 5-
LO to form 15-epi-LXA4 (Birnbaum et al., 2006; Spite and
Serhan, 2010; for review). This may explain, in part, the
signiﬁcant presence of amounts of this analogue at 48 h in
both monocultures and co-cultures. Again, our results
indicate that CTX is able to stimulate macrophages to
secrete mediators critical for tumour control, particularly
by formation of 15-epi-LXA4, and reinforce the antitumour
potential of these agents.
Studies have demonstrated that differently of the other
immunosuppressive agents such as glucocorticoids, LXs
and their analogues (ATL) selectively regulate the secretory
activity of macrophages (Aliberti et al., 2002a, 2002b;
Parkinson, 2006; for review). In in vivo and in vitro
studies, ATL did not compromise the ability of INF-g-
stimulated macrophages to kill intracellular parasites or to
up-regulate iNOS or nitric oxide synthesis, which are key
antimicrobial mechanisms of macrophages. These obser-
vations provided evidence that the LXs and their analogues
are immunomodulatory rather than immunosuppressive
(Aliberti et al., 2002b; Parkinson, 2006; for review). In
addition, the modulation of macrophage function by
immunoregulatory stimuli suggests a new immunothera-
peutic strategy (Zhang et al., 2012).
In conclusion, our data demonstrate, for the ﬁrst time,
the ability of CTX to selectively modulate the secretory
activity of macrophages co-cultured with tumour cells,
which may contribute to the inhibitory effect of this toxin
on tumour growth observed in in vivo studies, and reinforce
the immunomodulatory and antitumour effects of CTX.
Additionally, the activation of formyl peptide receptors,
LXA4 and the ATL receptor (ALX-R/FPRL-1) plays a major
role in these effects. Therefore, the macrophage activation
activity of CTX could provide new perspectives regardingthe development of substances with therapeutic
properties.
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